Skip to content

A retrospective analysis of a prospectively collected database on the safety and effectiveness of preemptive esophageal dilatation in the management of high-grade food bolus obstruction in the upper esophagus

A retrospective analysis of a prospectively collected database on the safety and effectiveness of preemptive esophageal dilatation in the management of high-grade food bolus obstruction in the upper esophagus

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12621001437853
Enrollment
456
Registered
2021-10-25
Start date
2018-06-18
Completion date
2019-09-30
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We propose to assess the safety and effectiveness of esophageal dilation at the time of food bolus disimpaction in reducing the risk of recurrent FBO in a retrospective analysis of a prospective database from 2008 to 2017. We aim to compare patients who undergo concurrent esophageal dilation using Savary Gillard dilator catheters at the time of food bolus disimpaction and those who have elective esophageal dilation as an outpatient. We expect that the concurrent esophageal dilation at the time of initial removal of food bolus is safe and effective in reducing the risk of recurrent FBO given it will treat the underlying pathology and stretch the esophagus. As a consequence, the patient does not need to return to hospital for a second endoscopy or represent to hospital with recurrent FBO. This would not only reduce health care cost but also reduce the number of patients presenting to emergency department with recurrent FBO.

Interventions

We propose to assess the safety and effectiveness of esophageal dilation at the time of food bolus disimpaction in reducing the risk of recurrent FBO in a retrospective analysis of a prospective database from 2008 to 2017. We aim to compare patients who undergo concurrent esophageal dilation using Savary Gillard dilator catheters at the time of food bolus disimpaction and those who have elective esophageal dilation as an outpatient. a) Participant requirement (no involvement, the following dat

We propose to assess the safety and effectiveness of esophageal dilation at the time of food bolus disimpaction in reducing the risk of recurrent FBO in a retrospective analysis of a prospective database from 2008 to 2017. We aim to compare patients who undergo concurrent esophageal dilation using Savary Gillard dilator catheters at the time of food bolus disimpaction and those who have elective esophageal dilation as an outpatient. a) Participant requirement (no involvement, the following data will be collected from each case: • Demographic data, • Clinical presentations • Underlying pathology • Mucosal damage to the esophagus and larynx • Complications after endoscopy such as aspiration, sore throat, GI bleeding. • Hospital stay duration b) the duration of observation/follow-up per participant (Up to 48 hours post-enrolment and 10 days post-enrolment)

Sponsors

Royal Adelaide Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

• Age 18-90 years • Confirmed acute food bolus requiring endoscopy

Exclusion criteria

• Age <18 • Patients managed medically, not requiring endoscopic retrieval of food bolus

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026